These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15365198)

  • 21. Preventing pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kubiliun NM; Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2013 Oct; 23(4):769-86. PubMed ID: 24079789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
    Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
    JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis of post-ERCP pancreatitis: a practice survey.
    Dumonceau JM; Rigaux J; Kahaleh M; Gomez CM; Vandermeeren A; Devière J
    Gastrointest Endosc; 2010 May; 71(6):934-9, 939.e1-2. PubMed ID: 20226455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative drainage in pancreatic cancer.
    Tsujino T; Isayama H; Koike K
    N Engl J Med; 2010 Apr; 362(14):1343-4; author reply 1346. PubMed ID: 20380028
    [No Abstract]   [Full Text] [Related]  

  • 25. ERCP and prophylactic pancreatic stents: raising the bar, reducing the pain.
    Silverman WB
    Gastrointest Endosc; 2007 Jun; 65(7):969-70. PubMed ID: 17531629
    [No Abstract]   [Full Text] [Related]  

  • 26. Utility of placement of pancreatic duct spontaneous dislodgement stent for prevention of post-ERCP pancreatitis in patients with difficulty in selective biliary cannulation.
    Sakai Y; Tsuyuguchi T; Mikata R; Tawada K; Tada M; Togo S; Tamura R; Saito M; Kurosawa J; Ishihara T; Yokosuka O
    Hepatogastroenterology; 2011; 58(107-108):687-93. PubMed ID: 21830369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of thalidomide in experimental models of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Xiong GS; Wu SM; Wang ZH; Mo JZ; Xiao SD
    J Gastroenterol Hepatol; 2007 Mar; 22(3):371-6. PubMed ID: 17295769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the rate of post-ERCP pancreatitis not reduced by guide-wire cannulation?
    Park DH; Lee SS; Seo DW; Lee SK; Kim MH
    Endoscopy; 2008 Sep; 40(9):784; author reply 785. PubMed ID: 18773344
    [No Abstract]   [Full Text] [Related]  

  • 29. Post-ERCP pancreatitis and its prevention.
    Frank CD; Adler DG
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):680-8. PubMed ID: 17130878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic stent prophylaxis of post endoscopic retrograde cholangiopancreatography pancreatitis: spontaneous migration rates and clinical outcomes.
    Chahal P; Baron TH; Petersen BT; Topazian MD; Gostout CJ; Levy MJ
    Minerva Gastroenterol Dietol; 2007 Sep; 53(3):225-30. PubMed ID: 17912184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Single Versus Dual Prophylactic Modalities.
    Abdelfatah MM; Gochanour E; Koutlas NJ; Othman MO
    Pancreas; 2019 Apr; 48(4):e24. PubMed ID: 30973466
    [No Abstract]   [Full Text] [Related]  

  • 32. Endoscopic approach to acute pancreatitis.
    Kinney TP; Lai R; Freeman ML
    Rev Gastroenterol Disord; 2006; 6(3):119-35. PubMed ID: 16957653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In patients undergoing precut biliary sphincterotomy during endoscopic retrograde cholangiopancreatography (ERCP) to facilitate biliary access, is endoscopic pancreatic duct stenting indicated to prevent pancreatitis?].
    Igea Arisqueta F
    Gastroenterol Hepatol; 2009 Mar; 32(3):171-2. PubMed ID: 19231033
    [No Abstract]   [Full Text] [Related]  

  • 34. Pancreatic stent placement remains a cornerstone of prevention of post-ERCP pancreatitis, but it requires specialized techniques.
    Arain MA; Freeman ML
    Gastrointest Endosc; 2015 Jan; 81(1):156-8. PubMed ID: 25527054
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy Versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis.
    Andriulli A; Loperfido S
    Am J Gastroenterol; 2007 Jul; 102(7):1539. PubMed ID: 17593163
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacologic prevention of post-ERCP pancreatitis: is nitroglycerin a sangreal?
    Muralidharan V; Jamidar P
    Gastrointest Endosc; 2006 Sep; 64(3):358-60. PubMed ID: 16923482
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological prevention of post-ERCP pancreatitis: the facts and the fiction.
    Testoni PA
    JOP; 2004 Jul; 5(4):171-8. PubMed ID: 15254345
    [No Abstract]   [Full Text] [Related]  

  • 38. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A survey of physician practices on prophylactic pancreatic stents.
    Brackbill S; Young S; Schoenfeld P; Elta G
    Gastrointest Endosc; 2006 Jul; 64(1):45-52. PubMed ID: 16813802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of ERCP.
    ; Anderson MA; Fisher L; Jain R; Evans JA; Appalaneni V; Ben-Menachem T; Cash BD; Decker GA; Early DS; Fanelli RD; Fisher DA; Fukami N; Hwang JH; Ikenberry SO; Jue TL; Khan KM; Krinsky ML; Malpas PM; Maple JT; Sharaf RN; Shergill AK; Dominitz JA
    Gastrointest Endosc; 2012 Mar; 75(3):467-73. PubMed ID: 22341094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.